Evidence map›Paper›PMID 38770219›Full record

ReviewNeuro-oncology advances

A brain metastasis liquid biopsy: Where are we now?

Stephen David Robinson, James de Boisanger, Frances M G Pearl, Giles Critchley, Nicola Rosenfelder, Georgios Giamas

Abstract readReview
In one paragraph

Review in Neuro-oncology advances. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. A Practical, Short, [Journal of clinical medicine · 2025
    Article
  10. Molecular Underpinnings of Brain Metastases.International journal of molecular sciences · 2025
    Review
  11. Review
  12. Review
  13. Improvement of small extracellular vesicle isolation from mouse model blood.Extracellular vesicles and circulating nucleic acids · 2025
    Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Stephen David RobinsonSussex Cancer Centre, University Hospitals Sussex NHS Foundation Trust, Brighton, UK.ORCID https://orcid.org/0000-0003-0623-4636
James de BoisangerNeuro-Oncology Unit, The Royal Marsden Hospital NHS Foundation Trust, London, UK.ORCID https://orcid.org/0000-0002-3919-7926
Frances M G PearlDepartment of Biochemistry and Biomedicine, School of Life Sciences, University of Sussex, Falmer, Brighton, UK.ORCID https://orcid.org/0000-0002-8210-4393
Giles CritchleyDepartment of Neurosurgery, University Hospitals Sussex NHS Foundation Trust, Brighton, UK.ORCID https://orcid.org/0009-0008-2628-8176
Nicola RosenfelderNeuro-Oncology Unit, The Royal Marsden Hospital NHS Foundation Trust, London, UK.ORCID https://orcid.org/0000-0001-7109-4815
Georgios GiamasDepartment of Biochemistry and Biomedicine, School of Life Sciences, University of Sussex, Falmer, Brighton, UK.ORCID https://orcid.org/0000-0002-4417-2707

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Brain metastases remain a challenging and feared complication for patients with cancer and research in this area has lagged behind research into metastases to other organs. Due to their location and the risks associated with neurosurgical biopsies, the biology underpinning brain metastases response to treatment and evolution over time remains poorly understood. Liquid biopsies are proposed to overcome many of the limitations present with tissue biopsies, providing a better representation of tumor heterogeneity, facilitating repeated sampling, and providing a noninvasive assessment of tumor biology. Several different liquid biopsy approaches have been investigated including circulating tumor cells, circulating tumor DNA, extracellular vesicles, and tumor-educated platelets; however, these have generally been less effective in assessing brain metastases compared to metastases to other organs requiring improved techniques to investigate these approaches, studies combining different liquid biopsy approaches and/or novel liquid biopsy approaches. Through this review, we highlight the current state of the art and define key unanswered questions related to brain metastases liquid biopsies.

Indexed as

brain metastasescirculating tumor cellscirculating tumor DNAextracellular vesiclesliquid biopsy

Identifiers

PMID38770219
PMCPMC11102938

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.